GSK, formerly GlaxoSmithKline, is headquartered in London and focuses on vaccines, HIV, respiratory and immunology, with products including the shingles vaccine Shingrix, the RSV vaccine Arexvy and the HIV therapy Tivicay. GSK launched the world's first RSV and malaria vaccines.
GSK faces generic competition in respiratory drugs and strong vaccine rivals.
